Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine and Insulin for Stress Hyperglycemia
NCT02806999Phase 4Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jul 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Stress Hyperglycemia (SH) comparing Berberine + Insulin with Placebo + Insulin (2 arms). Primary endpoint: Evidence of effects of insulin and berberine on stress hyperglycemia at 10 days. Status: unknown.
02
Drugs
berberine
03
Conditions
Stress Hyperglycemia (SH)
Beyond the preview
Go deeper on NCT02806999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806999.